Simultaneous newborn screening for sickle cell disease, biotinidase deficiency, and hereditary tyrosinemia type 1 with an optimized tandem mass spectrometry protocol

Ann Hematol. 2022 Aug;101(8):1859-1860. doi: 10.1007/s00277-022-04811-0. Epub 2022 Mar 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anemia, Sickle Cell* / complications
  • Anemia, Sickle Cell* / diagnosis
  • Biotinidase Deficiency* / diagnosis
  • Humans
  • Infant, Newborn
  • Neonatal Screening
  • Tandem Mass Spectrometry / methods
  • Tyrosinemias* / complications
  • Tyrosinemias* / diagnosis